Cannassure Therapeutics Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Sales 2022 | 33.78 129.27 2.7K | Sales 2023 | 11 42.08 880.61 | Capitalization | 4M 15.31M 320M |
---|---|---|---|---|---|
Net income 2022 | -5M -19.13M -400M | Net income 2023 | -1M -3.83M -80.07M | EV / Sales 2022 | 1,023,292 x |
Net Debt 2022 | 29.96M 115M 2.4B | Net Debt 2023 | 434K 1.66M 34.75M | EV / Sales 2023 | 403,186 x |
P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.66% |
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 30/03/22 |
Nir Peles
CHM | Chairman | 50 | 03/12/18 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 25/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 03/12/18 |
Nir Peles
CHM | Chairman | 50 | 03/12/18 |
Varda Kalal
BRD | Director/Board Member | 56 | 13/02/22 |
1st Jan change | Capi. | |
---|---|---|
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-42.17% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |